Literature DB >> 15726776

The socioeconomic impact of malaria in Colombia and Ecuador.

W Ruiz1, A Kroeger.   

Abstract

In-depth studies in three communities of Colombia and Ecuador, over a period of two to three months in each, were the basis of the economic analysis presented in this paper. In Santa Cruz, located at the rio Naya in Colombia, the average cost per case of malaria was US$17.30 (indirect costs US$15.80 and direct costs US$1.50); the loss corresponded to 20.1% of a minimum monthly wage (1986) or to a value of 5.6 days' work. In Perla de Sade, in the Cant6n Quininde of Ecuador, the average cost per case of malaria amounted to US$10.40 (indirect costs US$5.90 and direct costs US$4.50); the losses corresponded to 20.8% of a minimum monthly wage (1989) and to a value of 5.7 days' work. In Calder6n in the Cant6n of San Lorenzo in Ecuador, the average cost per case of malaria was US$4.80 (indirect costs US$3.50 and direct costs US$1.30); the losses corresponded to 16.0% of a minimum monthly wage (1991) with a value of 4.4 days' work. The results in these three communities, and in four additional ones, showed that the major economic impact of malaria is in the reduction of the labour force of families (indirect costs), and less so in the direct costs of care and cure. This emphasizes the economic importance of malaria because the rural familes with economies at subsistence level depend for survival particularly upon the maintenance of their labour force.

Entities:  

Mesh:

Year:  1994        PMID: 15726776     DOI: 10.1093/heapol/9.2.144

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  7 in total

Review 1.  Systematic review of microeconomic analysis of pregnancy-associated malaria.

Authors:  Deisy Cristina Restrepo-Posada; Jaime Carmona-Fonseca; Jaiberth Antonio Cardona-Arias
Journal:  Heliyon       Date:  2020-07-30

2.  Identification and Immunological Characterization of the Ligand Domain of Plasmodium vivax Reticulocyte Binding Protein 1a.

Authors:  Francis B Ntumngia; Richard Thomson-Luque; Sandra Galusic; Gabriel Frato; Sarah Frischmann; David S Peabody; Bryce Chackerian; Marcelo U Ferreira; Christopher L King; John H Adams
Journal:  J Infect Dis       Date:  2018-08-24       Impact factor: 5.226

Review 3.  Progress towards the development of a P. vivax vaccine.

Authors:  Sai Lata De; Francis B Ntumngia; Justin Nicholas; John H Adams
Journal:  Expert Rev Vaccines       Date:  2021-03-04       Impact factor: 5.217

4.  Predictive modeling of anti-malarial molecules inhibiting apicoplast formation.

Authors:  Salma Jamal; Vinita Periwal; Vinod Scaria
Journal:  BMC Bioinformatics       Date:  2013-02-15       Impact factor: 3.169

Review 5.  Why is Plasmodium vivax a neglected tropical disease?

Authors:  Jane M Carlton; Barbara J Sina; John H Adams
Journal:  PLoS Negl Trop Dis       Date:  2011-06-28

6.  Malaria Knowledge, Concern, Land Management, and Protection Practices among Land Owners and/or Managers in Lowland versus Highland Ecuador.

Authors:  Lauren L Pinault; Fiona F Hunter
Journal:  Malar Res Treat       Date:  2012-01-26

7.  Patients' costs, socio-economic and health system aspects associated with malaria in pregnancy in an endemic area of Colombia.

Authors:  Elisa Sicuri; Azucena Bardají; Sergi Sanz; Sergi Alonso; Silke Fernandes; Kara Hanson; Myriam Arevalo-Herrera; Clara Menéndez
Journal:  PLoS Negl Trop Dis       Date:  2018-05-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.